Mr. Dvořáček, in 2010, the AIFP commissioned a study on the economic footprint of the innovative pharmaceutical industry in the Czech Republic. Can you begin by…
In Conversation
Mr. Kotek, can you please begin by introducing us to the SVOPL and telling us what the mission is here in the Czech Republic? We are…
There have been a lot of changes in the Mexican pharmaceutical industry in the last four to five years, most notably the new drug registration process…
Mr. Jaouni, what do you understand as the vision of the Ali Bin Ali family in betting on the medical field and establishing Ali Bin Ali…
Sanofi acquired Kendrick in 2009. Obviously the thinking behind it was to diversify your products into pure generics, but what were the expectations for the move?…
Mexico is number one in child obesity and number two in adult obesity in the world. This is one of the reasons that diabetes is rapidly…
Mr. Shehata, one year after you joined Aamal Medical, Aamal Company went public on the Qatar stock exchange. How did the listing affect your operations at…
You have been Levant manager for 5 years now and the one that set up AstraZeneca in Jordan. How challenging has it been to establish the…
What have been the key milestones and accomplishments in the company development since you took the helm almost four years ago? First of all, and for…
Mr. Alderbesti, can you please begin by giving our readers an overview of the core agenda of the Investment Promotion Department of the Qatari Ministry of…
One of the key missions of the hospital is to set a new standard of healthcare in the Kingdom of Jordan and the region. To which…
We are here with a very young company, created in 2009, so only three years old. As you mentioned before the interview, you first started to…
